Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hematology news: LY-294002 activates apoptotic pathway in myeloid leukemia cells

Dec. 5, 2000

Chemically modified homoharringtonine analogue retains activity against resistant leukemia cells

Dec. 5, 2000

Anticancer tyrosine kinase inhibitors covered in patent issued to American Cyanamid

Dec. 5, 2000

Genzyme Transgenics to produce huN901 for ImmunoGen

Dec. 5, 2000

BioChem Pharma's Troxatyl to enter new clinical trial for CML-BP treatment

Dec. 5, 2000

INGN-241 is third Introgen drug candidate to enter clinical trials

Dec. 5, 2000

Korean researchers discover new series of protein farnesyltransferase inhibitors

Dec. 4, 2000

Japanese patent covers new steroidal antiproliferative compounds identified at Kaneka

Dec. 4, 2000

Nelarabine + fludarabine has significant activity, acceptable toxicity in refractory leukemias

Dec. 4, 2000

CDK-inhibitory pyrazolobenzodiazepines for cancer

Dec. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...